Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Vaccine research and development: tuberculosis as a global health threat.

Usman MM, Ismail S, Teoh TC.

Cent Eur J Immunol. 2017;42(2):196-204. doi: 10.5114/ceji.2017.69362. Epub 2017 Aug 8. Review.

2.

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.

Gálvez NMS, Soto JA, Kalergis AM.

Int J Mol Sci. 2017 Aug 11;18(8). pii: E1753. doi: 10.3390/ijms18081753. Review.

3.

Checkpoint inhibitors in the treatment of urological malignancies.

Popovic LS, Matovina-Brko G, Popovic M.

ESMO Open. 2017 Jun 23;2(2):e000165. doi: 10.1136/esmoopen-2017-000165. eCollection 2017. Review.

4.

BCG - old workhorse, new skills.

Gengenbacher M, Nieuwenhuizen NE, Kaufmann S.

Curr Opin Immunol. 2017 Jul 15;47:8-16. doi: 10.1016/j.coi.2017.06.007. [Epub ahead of print] Review.

5.

Novel vaccination approaches to prevent tuberculosis in children.

Triccas JA, Counoupas C.

Pneumonia (Nathan). 2016 Nov 24;8:18. doi: 10.1186/s41479-016-0020-z. eCollection 2016. Review.

6.

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

Brennan MJ, Tanner R, Morris S, Scriba TJ, Achkar JM, Zelmer A, Hokey DA, Izzo A, Sharpe S, Williams A, Penn-Nicholson A, Erasmus M, Stylianou E, Hoft DF, McShane H, Fletcher HA.

Clin Vaccine Immunol. 2017 Sep 5;24(9). pii: e00142-17. doi: 10.1128/CVI.00142-17. Print 2017 Sep. Review.

7.

The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus.

Barberis I, Bragazzi NL, Galluzzo L, Martini M.

J Prev Med Hyg. 2017 Mar;58(1):E9-E12. Review.

8.

Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?

Moliva JI, Turner J, Torrelles JB.

Front Immunol. 2017 Apr 5;8:407. doi: 10.3389/fimmu.2017.00407. eCollection 2017. Review.

9.
10.

A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.

Bellmunt J, Powles T, Vogelzang NJ.

Cancer Treat Rev. 2017 Mar;54:58-67. doi: 10.1016/j.ctrv.2017.01.007. Epub 2017 Feb 2. Review.

11.

Nanotechnology-Based Approach in Tuberculosis Treatment.

Nasiruddin M, Neyaz MK, Das S.

Tuberc Res Treat. 2017;2017:4920209. doi: 10.1155/2017/4920209. Epub 2017 Jan 22. Review.

12.

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection.

Warren E, Teskey G, Venketaraman V.

J Clin Med. 2017 Feb 7;6(2). pii: E15. doi: 10.3390/jcm6020015. Review.

13.

Experimental animal modelling for TB vaccine development.

Cardona PJ, Williams A.

Int J Infect Dis. 2017 Mar;56:268-273. doi: 10.1016/j.ijid.2017.01.030. Epub 2017 Feb 3. Review.

14.

Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model.

Rao M, Cadieux N, Fitzpatrick M, Reed S, Arsenian S, Valentini D, Parida S, Dodoo E, Zumla A, Maeurer M.

Int J Infect Dis. 2017 Mar;56:274-282. doi: 10.1016/j.ijid.2017.01.024. Epub 2017 Feb 2. Review.

15.

[Potential neurocognitive consequences of infection by human respiratory syncytial virus].

Flores JC, Bohmwald K, Espinoza J, Jara C, Peña M, Hoyos-Bachiloglu R, Iturriaga C, Kalergis AM, Borzutzky A.

Rev Chilena Infectol. 2016 Oct;33(5):537-542. doi: 10.4067/S0716-10182016000500008. Review. Spanish.

16.

Microevolution of BCG substrains.

Krysztopa-Grzybowska K, Lutyńska A.

Postepy Hig Med Dosw (Online). 2016 Dec 21;70(0):1259-1266. Review.

17.

Novel approaches to tuberculosis vaccine development.

Kaufmann SH, Weiner J, von Reyn CF.

Int J Infect Dis. 2017 Mar;56:263-267. doi: 10.1016/j.ijid.2016.10.018. Epub 2016 Nov 2. Review.

19.

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.

Higgins JP, Soares-Weiser K, López-López JA, Kakourou A, Chaplin K, Christensen H, Martin NK, Sterne JA, Reingold AL.

BMJ. 2016 Oct 13;355:i5170. doi: 10.1136/bmj.i5170. Review.

20.

Non-specific immunological effects of selected routine childhood immunisations: systematic review.

Kandasamy R, Voysey M, McQuaid F, de Nie K, Ryan R, Orr O, Uhlig U, Sande C, O'Connor D, Pollard AJ.

BMJ. 2016 Oct 13;355:i5225. doi: 10.1136/bmj.i5225. Review.

Supplemental Content

Loading ...
Support Center